Search filters

List of works by Clemens-Martin Wendtner

A novel hierarchical prognostic model of AML solely based on molecular mutations

scientific article published on 20 August 2012

Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial

scientific article published on 9 November 2016

B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides

scientific article published on 27 August 2012

BRAF inhibition in hairy cell leukemia with low-dose vemurafenib

scientific article

Basophils go wild when mosquitoes bite CLL.

scientific article published on 16 May 2016

Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia

scientific article published on 8 December 2015

Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group

scientific article

Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group

scientific article

CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes

scientific article published in June 2007

CD28 costimulation Impairs the efficacy of a redirected t-cell antitumor attack in the presence of regulatory t cells which can be overcome by preventing Lck activation

scientific article published on 15 February 2011

Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cells

scientific article

Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection

scientific article

Comparison of the effects of two kinase inhibitors, sorafenib and dasatinib, on chronic lymphocytic leukemia cells

scientific article

Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG).

scientific article published on 30 October 2008

Contact investigation for imported case of Middle East respiratory syndrome, Germany

scientific article published on April 2014

Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia

scientific article published on June 2017

Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia

scientific article

Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction

scientific article

Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors.

scientific article published on September 2002

Enhancement of gene transfer with recombinant adeno-associated virus (rAAV) vectors into primary B-cell chronic lymphocytic leukemia cells by CpG-oligodeoxynucleotides

scientific article published in December 2003

Eradication of minimal residual disease in chronic lymphocytic leukemia

scientific article published on January 2008

Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia

scientific article

FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia

scientific article published on 29 June 2016

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes

scientific article

Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia

scientific article

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority tri

scientific article published on 20 May 2016

First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab

scientific article

High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors

scientific article published in February 2003

Human Ly9 (CD229) as novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (B-CLL) recognized by autologous CD8+ T cells

scientific article published in July 2006

Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study

scientific article published on 12 September 2017

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial

scientific article published on 20 October 2015

MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes

scientific article published in January 2006

Malignant Peripheral Nerve Sheath Tumor of the Scalp: Case Report and Review of the Literature ⬇️

scientific article published on July 26, 2011

Meningeal spread of blastic plasmacytoid dendritic cell neoplasm

scientific article

Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia

scientific article published on 15 October 2015

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

scientific article

Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel

scientific article published on February 2010

Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update

scientific article

Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG).

scientific article published on 27 August 2015

Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia

scientific article

Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation

scientific article

Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group

scientific article published on 12 June 2013

Subtotal spleen necrosis

scientific article

The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progression

scientific article

The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes

scientific article published on 12 June 2008

The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature

scientific article

There is life in the old dog yet: thymidine kinase as predictive marker in diffuse large B-cell lymphoma ⬇️

scientific article published on July 16, 2013

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

scientific article

Use of eculizumab in refractory gemcitabine-induced thrombotic microangiopathy

scientific article published on 4 December 2013

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

scientific article

What should standard frontline therapy be in older patients with chronic lymphocytic leukemia? Chemoimmunotherapy should be standard frontline therapy

scientific article

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

scientific article

miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL.

scientific article published on 10 February 2015

Paulina is supported by:

About Paulina

Help